Vir Biotechnology stock has climbed to a fresh 52-week high, with investors watching the upcoming Mo

Vir Biotechnology (NASDAQ:VIR) Sets New 1-Year High - What

Vir Biotechnology stock has climbed strongly in recent weeks, with investors now watching its upcomi

Vir Biotechnology (NASDAQ:VIR) Shares Up 4.8% - Should You Buy?

Deutsche Bank AG compró una nueva posición en acciones de Vir Biotechnology, Inc. (NASDAQ:VIR - Informe gratuito) durante el segundo trimestre, según la compañía en su divulgación más reciente ante la Comisión de Bolsa y Valores. El fondo compró 134.258 acciones de la empresa.

BlackRock Inc. purchased a new stake in shares of Vir Biotechnology, Inc. (NASDAQ:VIR - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 20,678,283 shares of the company

ARCH Venture Management LLC purchased a new stake in shares of Vir Biotechnology, Inc. (NASDAQ:VIR - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 12,694,163 shares of the

ADAR1 Capital Management LLC bought a new stake in Vir Biotechnology, Inc. (NASDAQ:VIR - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2,456,677 shares of the company